Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly

Pharmaceutical heavyweight Novo Nordisk on Tuesday announced it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.